---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/283859936.md"
description: "Altimmune shares are trading lower after the company announced the pricing of its $225 million oversubscribed public offering of 64.25 million shares at $3.00 per share."
datetime: "2026-04-23T14:56:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/283859936.md)
  - [en](https://longbridge.com/en/news/283859936.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/283859936.md)
---

# 

Altimmune shares are trading lower after the company announced the pricing of its $225 million oversubscribed public offering of 64.25 million shares at $3.00 per share.

### Related Stocks

- [ALT.US](https://longbridge.com/en/quote/ALT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

## Related News & Research

- [Tiziana Announces New Positive Clinical Data For Intranasal Foralumab In Non-Active Secondary Progressive Multiple Sclerosis](https://longbridge.com/en/news/286899753.md)
- [Immix Biopharma Announces 95% Complete Response Rate In Interim Update From Relapsed/Refractory AL Amyloidosis Clinical Trial NEXICART-2](https://longbridge.com/en/news/287200923.md)
- [Rani Therapeutics Q1 contract revenue rises on Chugai collaboration; announces CFO transition](https://longbridge.com/en/news/286608288.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Liminatus Pharma Announces Proposed Merger with InnocsAI to Expand Oncology Cell Therapy Pipeline | LIMN Stock News](https://longbridge.com/en/news/287218720.md)